|
|
Volumn 88, Issue 2, 2008, Pages 168-169
|
|
TMC-207
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 (6 BROMO 2 METHOXY 3 QUINOLINYL) 4 DIMETHYLAMINO 2 (1 NAPHTHYL) 1 PHENYL 2 BUTANOL;
AMIKACIN;
ETHAMBUTOL;
ISONIAZID;
MOXIFLOXACIN;
PYRAZINAMIDE;
RIFAMPICIN;
STREPTOMYCIN;
ABSENCE OF SIDE EFFECTS;
ADD ON THERAPY;
CLINICAL TRIAL;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG SAFETY;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG TARGETING;
DRUG TOLERABILITY;
GENE MUTATION;
HUMAN;
IN VITRO STUDY;
IN VIVO STUDY;
MICROBIAL ACTIVITY;
MONOTHERAPY;
MYCOBACTERIUM SMEGMATIS;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
SINGLE DRUG DOSE;
WILD TYPE;
ANIMALS;
ANTITUBERCULAR AGENTS;
HUMANS;
QUINOLINES;
TREATMENT OUTCOME;
TUBERCULOSIS;
|
|
EID: 43249129871
PISSN: 14729792
EISSN: None
Source Type: Journal
DOI: 10.1016/S1472-9792(08)70029-5 Document Type: Review |
|
Times cited : (8)
|
|
References (5)
|
